Outset Medical, Inc. Other-than-temporary Impairment Loss, Debt Securities, Available-for-sale, Recognized in Earnings
Outset Medical, Inc. (OM) reported Other-than-temporary Impairment Loss, Debt Securities, Available-for-sale, Recognized in Earnings of $0 for the 12-month period ending 2022-12-31, per its 10-K filed 2023-02-13.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings · last filed 2023-02-13
- Outset Medical, Inc. other-than-temporary impairment loss, debt securities, available-for-sale, recognized in earnings for the quarter ending 2022-12-31 was $0.00.
- Outset Medical, Inc. other-than-temporary impairment loss, debt securities, available-for-sale, recognized in earnings for the quarter ending 2022-09-30 was $0.00.
- Outset Medical, Inc. other-than-temporary impairment loss, debt securities, available-for-sale, recognized in earnings for the quarter ending 2022-06-30 was $0.00.
- Outset Medical, Inc. other-than-temporary impairment loss, debt securities, available-for-sale, recognized in earnings for the quarter ending 2022-03-31 was $0.00.
- Outset Medical, Inc. other-than-temporary impairment loss, debt securities, available-for-sale, recognized in earnings for fiscal 2022 was $0.00.
- Outset Medical, Inc. other-than-temporary impairment loss, debt securities, available-for-sale, recognized in earnings for fiscal 2021 was $0.00.
- Outset Medical, Inc. other-than-temporary impairment loss, debt securities, available-for-sale, recognized in earnings for fiscal 2020 was $0.00.
- Outset Medical, Inc. other-than-temporary impairment loss, debt securities, available-for-sale, recognized in earnings for fiscal 2019 was $0.00.
| Period end | Other-than-temporary Impairment Loss, Debt Securities, Available-for-sale, Recognized in Earnings 3 month | Other-than-temporary Impairment Loss, Debt Securities, Available-for-sale, Recognized in Earnings 6 month | Other-than-temporary Impairment Loss, Debt Securities, Available-for-sale, Recognized in Earnings 9 month | Other-than-temporary Impairment Loss, Debt Securities, Available-for-sale, Recognized in Earnings 12 month |
|---|---|---|---|---|
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-13 | $0.00 derived: sum of 2 quarters · filed 2023-02-13 | $0.00 derived: sum of 3 quarters · filed 2023-02-13 | $0.00 10-K · filed 2023-02-13 |
| 2022-09-30 | $0.00 10-Q · filed 2022-11-09 | $0.00 derived: sum of 2 quarters · filed 2022-11-09 | $0.00 10-Q · filed 2022-11-09 | $0.00 derived: sum of 4 quarters · filed 2023-02-13 |
| 2022-06-30 | $0.00 10-Q · filed 2022-08-02 | $0.00 10-Q · filed 2022-08-02 | $0.00 derived: sum of 3 quarters · filed 2023-02-13 | $0.00 derived: sum of 4 quarters · filed 2023-02-13 |
| 2022-03-31 | $0.00 10-Q · filed 2022-05-05 | $0.00 derived: sum of 2 quarters · filed 2023-02-13 | $0.00 derived: sum of 3 quarters · filed 2023-02-13 | $0.00 derived: sum of 4 quarters · filed 2023-02-13 |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-13 | $0.00 derived: sum of 2 quarters · filed 2023-02-13 | $0.00 derived: sum of 3 quarters · filed 2023-02-13 | $0.00 10-K · filed 2023-02-13 |
| 2021-09-30 | $0.00 10-Q · filed 2022-11-09 | $0.00 derived: sum of 2 quarters · filed 2022-11-09 | $0.00 10-Q · filed 2022-11-09 | $0.00 derived: sum of 4 quarters · filed 2023-02-13 |
| 2021-06-30 | $0.00 10-Q · filed 2021-08-06 | $0.00 10-Q · filed 2021-08-06 | $0.00 derived: sum of 3 quarters · filed 2023-02-13 | $0.00 derived: sum of 4 quarters · filed 2023-02-13 |
| 2021-03-31 | $0.00 10-Q · filed 2022-05-05 | $0.00 derived: sum of 2 quarters · filed 2023-02-13 | $0.00 derived: sum of 3 quarters · filed 2023-02-13 | $0.00 derived: sum of 4 quarters · filed 2023-02-13 |
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-13 | $0.00 derived: sum of 2 quarters · filed 2023-02-13 | $0.00 derived: sum of 3 quarters · filed 2023-02-13 | $0.00 10-K · filed 2023-02-13 |
| 2020-09-30 | $0.00 10-Q · filed 2021-11-04 | $0.00 derived: sum of 2 quarters · filed 2021-11-04 | $0.00 10-Q · filed 2021-11-04 | |
| 2020-06-30 | $0.00 10-Q · filed 2021-08-06 | $0.00 10-Q · filed 2021-08-06 | ||
| 2020-03-31 | $0.00 10-Q · filed 2021-05-06 | |||
| 2019-12-31 | $0.00 10-K · filed 2022-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| IRIDEX CORP (IRIX) | United States | $0.011B | |
| ENDRA Life Sciences Inc. (NDRA) | United States | $0.009B | |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| Nuwellis, Inc. (NUWE) | United States | $0.003B |